BRIEF-Axsome therapeutics gets pre-ind guidance from FDA for AXS-05
April 20, 2016 at 07:32 AM EDT
* Ind guidance from fda for AXS-05 for agitation in patients with alzheimer's disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|